BPG is committed to discovery and dissemination of knowledge
Featured Articles
9/2/2024 6:26:23 AM | Browse: 60 | Download: 32
|
Received |
|
2024-03-18 14:01 |
|
Peer-Review Started |
|
2024-03-18 14:01 |
|
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-07-28 06:55 |
|
Revised |
|
2024-08-10 01:06 |
|
Second Decision |
|
2024-08-16 04:41 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2024-08-16 08:27 |
|
Articles in Press |
|
2024-08-16 08:27 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2024-08-22 21:15 |
|
Typeset the Manuscript |
|
2024-08-26 01:46 |
|
Publish the Manuscript Online |
|
2024-09-02 03:59 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
Xing ZY, Zhang CJ, Liu LJ. Targeting both ferroptosis and pyroptosis may represent potential therapies for acute liver failure. World J Gastroenterol 2024; In press |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Editorial |
Article Title |
Targeting both ferroptosis and pyroptosis may represent potential therapies for acute liver failure
|
Manuscript Source |
Invited Manuscript |
All Author List |
Zhong-Yuan Xing, Chuan-Jie Zhang and Li-Juan Liu |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
The Hubei Provincial Natural Science Foundation of China |
No. 2020CFB656 |
|
Corresponding Author |
Li-Juan Liu, PhD, Lecturer, Department of Medical Microbiology, School of Basic Medical Sciences, Wuhan University, No. 185 Donghu Road, Wuhan 430071, Hubei Province, China. lijuanliu@whu.edu.cn |
Key Words |
Acute liver failure; Ferroptosis; Pyroptosis; Crosstalk; Silent information regulator sirtuin 1; P53; Glutathione peroxidase 4; Gasdermin D; Treatment |
Core Tip |
Acute liver failure (ALF) is a life-threatening disease characterized by uncontrolled death of hepatocytes. Ferroptosis and pyroptosis are two recently discovered types of cell death that can occur simultaneously. However, their roles in ALF remain unclear. The findings show that these two cell death pathways work together to advance ALF and suggest that silent information regulator sirtuin 1 (SIRT1) and its downstream molecules could be potential therapeutics for ALF. Therefore, we will discuss the roles and crosstalk of ferroptosis and pyroptosis in ALF. Activation of SIRT1 and suppression of both cell death pathways may offer new insights into therapeutic targets for ALF. |
Publish Date |
2024-09-02 03:59 |
Citation |
<p>Xing ZY, Zhang CJ, Liu LJ. Targeting both ferroptosis and pyroptosis may represent potential therapies for acute liver failure. <i>World J Gastroenterol</i> 2024; 30(33): 3791-3798</p> |
URL |
https://www.wjgnet.com/1007-9327/full/v30/i33/3791.htm |
DOI |
https://dx.doi.org/10.3748/wjg.v30.i33.3791 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345